Delestrogen and hepatic neoplasm malignant Patient Reports February 12, 2012

Delestrogen Side Effects Report #4751674-7
Delestrogen side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2004. Female patient, 50 years of age, was diagnosed with ovarian failure postoperative, menopausal symptoms and was treated with Delestrogen. After drug was administered, patient experienced the following side effects: breast cancer , hepatic neoplasm malignant, metastasis, oestrogen receptor assay positive, progesterone receptor assay positive, tumour embolism. Delestrogen dosage: 40 MG, QD. During the same period patient was treated with ESTRACE, ESTRATEST H, PREMARIN, PROVERA. Patient recovered.

Delestrogen Side Effects Report #5405250-3
Delestrogen side effect was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Female patient was diagnosed with ovarian failure postoperative, menopausal symptoms and was treated with Delestrogen. After drug was administered, patient experienced the following side effects: breast cancer , hepatic neoplasm malignant. Delestrogen dosage: 40 MG, QD. During the same period patient was treated with ESTRACE, PREMARIN, PROVERA, ESTRATEST H. Patient died on 03/20/2005.